{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T21:38:16Z","timestamp":1763415496496},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest Radiol"],"published-print":{"date-parts":[[2020,4]]},"abstract":"\n Rationale and Objectives<\/jats:title>\n Liver inflammation is associated with nonalcoholic steatohepatitis and other pathologies, but noninvasive methods to assess liver inflammation are limited. Inflammation causes endothelial disruption and leakage of plasma proteins into the interstitial space and can result in extravascular coagulation with fibrin deposition. Here we assess the feasibility of using the established fibrin-specific magnetic resonance probe EP-2104R for the noninvasive imaging of fibrin as a marker of liver inflammation.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n Weekly 100 mg\/kg diethylnitrosamine (DEN) dosing was used to generate liver fibrosis in male rats; control animals received vehicle. Magnetic resonance imaging at 1.5 T with EP-2104R, a matched non\u2013fibrin-binding control linear peptide, or the collagen-specific probe EP-3533 was performed at 1 day or 7 days after the last DEN administration. Imaging data were compared with quantitative histological measures of fibrosis and inflammation.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n After 4 or 5 DEN administrations, the liver becomes moderately fibrotic, and fibrosis is the same if the animal is killed 1 day (Ishak score, 3.62 \u00b1 0.31) or 7 days (Ishak score, 3.82 \u00b1 0.25) after the last DEN dose, but inflammation is significantly higher at 1 day compared with 7 days after the last DEN dose (histological activity index from 0\u20134, 3.54 \u00b1 0.14 vs 1.61 \u00b1 0.16, respectively; P<\/jats:italic> < 0.0001). Peak EP-2104R signal enhancement was significantly higher in animals imaged at 1 day post-DEN compared with 7 days post-DEN or control rats (29.0% \u00b1 3.2% vs 22.4% \u00b1 2.0% vs 17.0% \u00b1 0.2%, respectively; P<\/jats:italic> = 0.017). Signal enhancement with EP-2104R was significantly higher than control linear peptide at 1 day post-DEN but not at 7 days post-DEN indicating specific fibrin binding during the inflammatory phase. Collagen molecular magnetic resonance with EP-3533 showed equivalent T1 change when imaging rats 1 day or 7 days post-DEN, consistent with equivalent fibrosis.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n EP-2104R can specifically detect fibrin associated with inflammation in a rat model of liver inflammation and fibrosis.<\/jats:p>\n <\/jats:sec>","DOI":"10.1097\/rli.0000000000000631","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T20:46:13Z","timestamp":1577825173000},"page":"209-216","source":"Crossref","is-referenced-by-count":19,"title":["Molecular Magnetic Resonance Imaging of Fibrin Deposition in the Liver as an Indicator of Tissue Injury and Inflammation"],"prefix":"10.1097","volume":"55","author":[{"given":"Iliyana","family":"Atanasova","sequence":"first","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital"}]},{"given":"Mozhdeh","family":"Sojoodi","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"}]},{"given":"Helena S.","family":"Leit\u00e3o","sequence":"additional","affiliation":[{"name":"Department of Biomedical Sciences and Medicine and University Hospital Center, University of Algarve, Faro"}]},{"given":"Sergei","family":"Shuvaev","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital"}]},{"given":"Carlos F.G.C.","family":"Geraldes","sequence":"additional","affiliation":[{"name":"Department of Life Sciences and Coimbra Chemistry Center, Faculty of Science and Technology, University of Coimbra, Coimbra, Portugal"}]},{"given":"Ricard","family":"Masia","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, MA"}]},{"given":"Alexander S.","family":"Guimaraes","sequence":"additional","affiliation":[{"name":"Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital"}]},{"given":"Kenneth K.","family":"Tanabe","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"}]},{"given":"Bryan C.","family":"Fuchs","sequence":"additional","affiliation":[{"name":"Division of Surgical Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA"}]},{"given":"Peter","family":"Caravan","sequence":"additional","affiliation":[]}],"member":"276","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"key":"bib1-20230926","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.21347","article-title":"Global challenges in liver disease","volume":"44","year":"2006","journal-title":"Hepatology"},{"key":"bib2-20230926","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"bib3-20230926","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: a feature of the metabolic syndrome","volume":"50","year":"2001","journal-title":"Diabetes"},{"key":"bib4-20230926","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1148\/radiol.2017170550","article-title":"Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis","volume":"286","year":"2018","journal-title":"Radiology"},{"key":"bib5-20230926","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/hep.29797","article-title":"Noninvasive, quantitative assessment of liver fat by MRI-PDFF as an endpoint in NASH trials","volume":"68","year":"2018","journal-title":"Hepatology"},{"key":"bib6-20230926","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1530-0277.2008.00664.x","article-title":"Value of fibrosis markers for staging liver fibrosis in patients with precirrhotic alcoholic liver disease","volume":"32","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"bib7-20230926","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.jhep.2005.10.019","article-title":"Performance of serum marker panels for liver fibrosis in chronic hepatitis C","volume":"44","year":"2006","journal-title":"J Hepatol"},{"key":"bib8-20230926","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic resonance elastography vs transient elastography in detection of fibrosis and noninvasive measurement of steatosis in patients with biopsy-proven nonalcoholic fatty liver disease","volume":"152","year":"2017","journal-title":"Gastroenterology"},{"key":"bib9-20230926","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic resonance imaging more accurately classifies steatosis and fibrosis in patients with nonalcoholic fatty liver disease than transient elastography","volume":"150","year":"2016","journal-title":"Gastroenterology"},{"key":"bib10-20230926","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1148\/radiol.2017170595","article-title":"CM-101: Type I collagen-targeted MR imaging probe for detection of liver fibrosis","volume":"287","year":"2018","journal-title":"Radiology"},{"key":"bib11-20230926","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/hep4.1193","article-title":"Molecular magnetic resonance imaging accurately measures the antifibrotic effect of EDP-305, a novel farnesoid X receptor agonist","volume":"2","year":"2018","journal-title":"Hepatol Commun"},{"key":"bib12-20230926","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/hep.28930","article-title":"Combined magnetic resonance elastography and collagen molecular magnetic resonance imaging accurately stage liver fibrosis in a rat model","volume":"65","year":"2017","journal-title":"Hepatology"},{"key":"bib13-20230926","article-title":"Molecular imaging of oxidized collagen quantifies pulmonary and hepatic fibrogenesis","volume":"2","year":"2017","journal-title":"JCI Insight"},{"key":"bib14-20230926","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1148\/radiol.2017160588","article-title":"Molecular MR imaging of myeloperoxidase distinguishes steatosis from steatohepatitis in nonalcoholic fatty liver disease","volume":"284","year":"2017","journal-title":"Radiology"},{"key":"bib15-20230926","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1042\/bst0300194","article-title":"Coagulation cascade proteases and tissue fibrosis","volume":"30","year":"2002","journal-title":"Biochem Soc Trans"},{"key":"bib16-20230926","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.bbadis.2012.12.013","article-title":"Coagulation and coagulation signalling in fibrosis","volume":"1832","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"bib17-20230926","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/jth.12783","article-title":"Platelets and fibrin in progression of liver disease: friends or foes?","volume":"13","year":"2015","journal-title":"J Thromb Haemost"},{"key":"bib18-20230926","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/0016-5085(95)90211-2","article-title":"Accumulation and cellular localization of fibrinogen\/fibrin during short-term and long-term rat liver injury","volume":"108","year":"1995","journal-title":"Gastroenterology"},{"key":"bib19-20230926","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jth.12770","article-title":"Coagulation-driven platelet activation reduces cholestatic liver injury and fibrosis in mice","volume":"13","year":"2015","journal-title":"J Thromb Haemost"},{"key":"bib20-20230926","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1124\/jpet.114.218545","article-title":"Thrombin inhibition with dabigatran protects against high-fat diet-induced fatty liver disease in mice","volume":"351","year":"2014","journal-title":"J Pharmacol Exp Ther"},{"key":"bib21-20230926","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1021\/ja800834y","article-title":"EP-2104R: a fibrin-specific gadolinium-Based MRI contrast agent for detection of thrombus","volume":"130","year":"2008","journal-title":"J Am Chem Soc"},{"key":"bib22-20230926","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1161\/STROKEAHA.106.479998","article-title":"Molecular MRI of cerebral venous sinus thrombosis using a new fibrin-specific MR contrast agent","volume":"38","year":"2007","journal-title":"Stroke"},{"key":"bib23-20230926","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1097\/RLI.0b013e3181b092a7","article-title":"Thrombus imaging with fibrin-specific gadolinium-based MR contrast agent EP-2104R: results of a phase II clinical study of feasibility","volume":"44","year":"2009","journal-title":"Invest Radiol"},{"key":"bib24-20230926","article-title":"Uncoupling of the profibrotic and hemostatic effects of thrombin in lung fibrosis","volume":"2","year":"2017","journal-title":"JCI Insight"},{"key":"bib25-20230926","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/RLI.0b013e31825dddfb","article-title":"Molecular imaging of fibrin in a breast cancer xenograft mouse model","volume":"47","year":"2012","journal-title":"Invest Radiol"},{"key":"bib26-20230926","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/RLI.0b013e3181f7a0b0","article-title":"Evaluation of a fibrin-binding gadolinium chelate peptide tetramer in a brain glioma model","volume":"46","year":"2011","journal-title":"Invest Radiol"},{"key":"bib27-20230926","doi-asserted-by":"crossref","first-page":"8171","DOI":"10.1002\/anie.200700700","article-title":"Collagen-targeted MRI contrast agent for molecular imaging of fibrosis","volume":"46","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"bib28-20230926","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.jhep.2013.06.026","article-title":"Molecular MRI of collagen to diagnose and stage liver fibrosis","volume":"59","year":"2013","journal-title":"J Hepatol"},{"key":"bib29-20230926","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jhep.2015.04.029","article-title":"3D molecular MR imaging of liver fibrosis and response to rapamycin therapy in a bile duct ligation rat model","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"bib30-20230926","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","year":"1995","journal-title":"J Hepatol"},{"key":"bib31-20230926","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jhep.2012.04.035","article-title":"Molecular MR imaging of liver fibrosis: a feasibility study using rat and mouse models","volume":"57","year":"2012","journal-title":"J Hepatol"},{"key":"bib32-20230926","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","article-title":"Pathogenesis of liver fibrosis","volume":"6","year":"2011","journal-title":"Annu Rev Pathol"},{"key":"bib33-20230926","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000129132","article-title":"Effects of thromboxane A2 synthetase inhibitor on postischemic liver injury in rats","volume":"23","year":"1991","journal-title":"Eur Surg Res"},{"key":"bib34-20230926","first-page":"1238","article-title":"Hepatic and portal vein thrombosis in cirrhosis: possible role in development of parenchymal extinction and portal hypertension","volume":"21","year":"1995","journal-title":"Hepatology"},{"key":"bib35-20230926","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1111\/j.1572-0241.2007.01223.x","article-title":"Are chronic hepatitis C viral infections more benign in patients with hemophilia?","volume":"102","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"bib36-20230926","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1136\/gut.52.8.1206","article-title":"Factor V Leiden polymorphism and the rate of fibrosis development in chronic hepatitis C virus infection","volume":"52","year":"2003","journal-title":"Gut"},{"key":"bib37-20230926","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1007\/s10620-006-9595-1","article-title":"The beneficial effect of aspirin and enoxaparin on fibrosis progression and regenerative activity in a rat model of cirrhosis","volume":"52","year":"2007","journal-title":"Dig Dis Sci"},{"key":"bib38-20230926","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.jhep.2006.08.023","article-title":"Low molecular weight heparin prevents hepatic fibrogenesis caused by carbon tetrachloride in the rat","volume":"46","year":"2007","journal-title":"J Hepatol"},{"key":"bib39-20230926","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/j.1538-7836.2008.03015.x","article-title":"Coagulation status modulates murine hepatic fibrogenesis: implications for the development of novel therapies","volume":"6","year":"2008","journal-title":"J Thromb Haemost"},{"key":"bib40-20230926","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.ajpath.2012.06.011","article-title":"Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease","volume":"181","year":"2012","journal-title":"Am J Pathol"},{"key":"bib41-20230926","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.3748\/wjg.v9.i7.1611","article-title":"Effects of heparin on liver fibrosis in patients with chronic hepatitis B","volume":"9","year":"2003","journal-title":"World J Gastroenterol"},{"key":"bib42-20230926","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1053\/j.gastro.2012.07.018","article-title":"Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis","volume":"143","year":"2012","journal-title":"Gastroenterology"},{"key":"bib43-20230926","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1148\/radiol.10100881","article-title":"Bimodal thrombus imaging: simultaneous PET\/MR imaging with a fibrin-targeted dual PET\/MR probe\u2013feasibility study in rat model","volume":"258","year":"2011","journal-title":"Radiology"}],"container-title":["Investigative Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLI.0000000000000631","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T18:02:35Z","timestamp":1695751355000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLI.0000000000000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,31]]},"references-count":43,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/rli.0000000000000631","relation":{},"ISSN":["1536-0210","0020-9996"],"issn-type":[{"value":"1536-0210","type":"electronic"},{"value":"0020-9996","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12,31]]}}}